A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion.

[1]  P. Casey,et al.  Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases , 2013, Cell Death and Disease.

[2]  S. Mannava,et al.  Depletion of deoxyribonucleotide pools is an endogenous source of DNA damage in cells undergoing oncogene-induced senescence. , 2013, The American journal of pathology.

[3]  S. Mannava,et al.  Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion , 2012, Aging.

[4]  P. Roux,et al.  Cooperative Anti-Invasive Effect of Cdc42/Rac1 Activation and ROCK Inhibition in SW620 Colorectal Cancer Cells with Elevated Blebbing Activity , 2012, PloS one.

[5]  A. Hauschild,et al.  Progression of cutaneous melanoma: implications for treatment , 2012, Clinical & Experimental Metastasis.

[6]  Alissa M. Weaver,et al.  Adhesion rings surround invadopodia and promote maturation , 2012, Biology Open.

[7]  Chi V Dang,et al.  Links between metabolism and cancer. , 2012, Genes & development.

[8]  S. Noble,et al.  Mycophenolate Mofetil , 1999, BioDrugs.

[9]  Z. Werb,et al.  Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.

[10]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[11]  K. Nouri,et al.  Guanosine supplementation reduces the antiproliferative and apoptotic effects of the IMPDH inhibitor gnidilatimonoein in K562 cells , 2011, Cell biology international.

[12]  S. Courtneidge,et al.  The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.

[13]  Z. Kouchi,et al.  Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation , 2011, The Journal of cell biology.

[14]  A. Ridley.  Life at the Leading Edge , 2011, Cell.

[15]  Alexander Nürnberg,et al.  Nucleating actin for invasion , 2011, Nature Reviews Cancer.

[16]  E. Sahai,et al.  Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. , 2011, Cancer cell.

[17]  R. Worthylake,et al.  RhoA can lead the way in tumor cell invasion and metastasis. , 2011, Frontiers in bioscience.

[18]  C. Crews,et al.  Reversal of TNP-470-Induced Endothelial Cell Growth Arrest by Guanine and Guanine Nucleosides , 2010, Journal of Pharmacology and Experimental Therapeutics.

[19]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Takeharu Nagai,et al.  Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators , 2009, Proceedings of the National Academy of Sciences.

[21]  C. Thompson,et al.  The molecular determinants of de novo nucleotide biosynthesis in cancer cells. , 2009, Current opinion in genetics & development.

[22]  Michiel M T van Dommelen,et al.  Modulation of Cell Motility by Spatial Repositioning of Enzymatic ATP/ADP Exchange Capacity* , 2009, Journal of Biological Chemistry.

[23]  R. Buccione,et al.  Cell and molecular biology of invadopodia. , 2009, International review of cell and molecular biology.

[24]  K. Smalley,et al.  Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy. , 2009, Molecular diagnosis & therapy.

[25]  R. Buccione,et al.  Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix , 2009, Cancer and Metastasis Reviews.

[26]  Scott A. Guelcher,et al.  Extracellular Matrix Rigidity Promotes Invadopodia Activity , 2008, Current Biology.

[27]  K. Zeller,et al.  Global Regulation of Nucleotide Biosynthetic Genes by c-Myc , 2008, PloS one.

[28]  D. Zhuang,et al.  Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells , 2008, Cell cycle.

[29]  J. Settleman,et al.  p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho , 2006, Cell.

[30]  A. Ridley.  Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. , 2006, Trends in cell biology.

[31]  D. Schadendorf,et al.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.

[32]  C. Ji,et al.  Crystal structure of human guanosine monophosphate reductase 2 (GMPR2) in complex with GMP. , 2005, Journal of molecular biology.

[33]  J. Frost,et al.  PAK1 Negatively Regulates the Activity of the Rho Exchange Factor NET1* , 2005, Journal of Biological Chemistry.

[34]  P. Friedl,et al.  The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism , 2004, Journal of Cell Science.

[35]  Yue Zhang,et al.  Regulation of Cell Polarity and Protrusion Formation by Targeting RhoA for Degradation , 2003, Science.

[36]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[37]  S. Atkinson,et al.  Rho GTPases show differential sensitivity to nucleotide triphosphate depletion in a model of ischemic cell injury. , 2003, American journal of physiology. Cell physiology.

[38]  M. Huang,et al.  Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. , 2003, Blood.

[39]  D. Bar-Sagi,et al.  Redox-dependent downregulation of Rho by Rac , 2003, Nature Cell Biology.

[40]  Yi Zheng,et al.  Rho GTPase-activating proteins in cell regulation. , 2003, Trends in cell biology.

[41]  A. Hall,et al.  Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. , 2002, Genes & development.

[42]  Lichuan Yang,et al.  Measurements of ATP in mammalian cells. , 2002, Methods.

[43]  John G. Collard,et al.  Rac Affects Invasion of Human Renal Cell Carcinomas by Up-regulating Tissue Inhibitor of Metalloproteinases (TIMP)-1 and TIMP-2 Expression* , 2001, The Journal of Biological Chemistry.

[44]  B. Gumbiner,et al.  Cadherin Engagement Regulates Rho family GTPases* , 2001, The Journal of Biological Chemistry.

[45]  Jiahua Xu,et al.  Rac1 Mediates Type I Collagen-dependent MMP-2 Activation , 2001, The Journal of Biological Chemistry.

[46]  E. Sahai,et al.  Regulation of Mitogen-Activated Protein Kinases in Cardiac Myocytes through the Small G Protein Rac1 , 2001, Molecular and Cellular Biology.

[47]  H. Jayaram,et al.  Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis. , 2000, Anticancer research.

[48]  P. Franchetti,et al.  Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. , 1999, Current medicinal chemistry.

[49]  M. Grusch,et al.  Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis. , 1999, Current medicinal chemistry.

[50]  H. Kennedy,et al.  Glucose generates sub-plasma membrane ATP microdomains in single islet beta-cells. Potential role for strategically located mitochondria. , 1999, The Journal of biological chemistry.

[51]  S. Kuroda,et al.  Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. , 1999, Annual review of biochemistry.

[52]  Y. Xiong,et al.  Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. , 1998, Blood.

[53]  Y. Zheng,et al.  Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1. , 1998, Biochemistry.

[54]  L. Van Aelst,et al.  Rho GTPases and signaling networks. , 1997, Genes & development.

[55]  John G. Collard,et al.  Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells. , 1995, Oncogene.

[56]  J. Ransom.  Mechanism of Action of Mycophenolate Mofetil , 1995, Therapeutic drug monitoring.

[57]  John G. Collard,et al.  A role for Rac in Tiaml-induced membrane ruffling and invasion , 1995, Nature.

[58]  G. Weber,et al.  Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. , 1992, Cancer research.

[59]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.

[60]  F. Collart,et al.  Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs. , 1988, The Journal of biological chemistry.

[61]  H. Zalkin.  [34] GMP Synthetase , 1985 .

[62]  R. Miller,et al.  Reaction mechanism and specificity of human GMP reductase. Substrates, inhibitors, activators, and inactivators. , 1979, The Journal of biological chemistry.

[63]  Klein Wj,et al.  Lack of effect on cyclic GMP content of cells treated with mycophenolic acid. , 1977 .

[64]  E. B. Murphy,et al.  Lack of effect on cyclic GMP content of cells treated with mycophenolic acid. , 1977, Journal of cyclic nucleotide research.